Join us this webinar and get insights from Daniel Mak, Vice President at ChinaAMC (HK) on how you can capture the long-term growth opportunities in China and Hong Kong Biotechnology. There will be Q&A session at the end of the webinar too.
- Investment in thematic ETFs experienced a huge boom in the past year. What is the reason behind it?
- Do you know the biotech sector in Hong Kong outperformed Hang Seng Index as well as Hang Seng Tech Index year-to-date?
- What factors contribute to the robust performance of the biotech sector?
- Why is ETF a suitable vehicle to invest in the long-term prospect of biotech industry?
Sign up now to reserve your slot!